CKD Screening

A clinical tool used to aid in screening for CKD (chronic kidney disease).

Thirty million American adults are estimated by the Centers for Disease Control to be living with chronic kidney disease (CKD) today, with over 80% unaware of the condition that puts them at increased risk for cardiovascular events and progression to kidney failure and death. Almost 90% of adults with type-2 diabetes and CKD are not currently diagnosed, and as many as 50% of patients with advanced CKD (Stage G4) remain undiagnosed in primary care populations. Several national surveys have shown only 10 to 20% of Americans who have laboratory evidence of CKD are aware that they have the condition. While current clinical practice guidelines for CKD assessment recommend that adults with diabetes and/or hypertension be tested annually for albuminuria, there is underutilization of yearly urinary albumin-creatinine ratio testing in people at risk for CKD. Less than 10% of those with hypertension and less than 40% of those with diabetes are appropriately assessed.